Pro Vise Management Group, LLC Silk Road Medical Inc Transaction History

Pro Vise Management Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$28.03 - $45.8 $137,347 - $224,420	-4,900 Closed	0 $0
Q3 2021 Oct 20, 2021	SELL	$44.0 - $65.8 $22,000 - $32,900	-500 Reduced 9.26%	4,900 $270,000
Q2 2021 Aug 06, 2021	SELL	$44.66 - $63.06 $17,864 - $25,224	-400 Reduced 6.9%	5,400 $258,000
Q1 2021 Apr 22, 2021	SELL	$46.31 - $62.7 $11,577 - $15,675	-250 Reduced 4.13%	5,800 $294,000
Q4 2020 Jan 19, 2021	SELL	$55.51 - $69.94 $51,235 - $64,554	-923 Reduced 13.24%	6,050 $381,000
Q3 2020 Oct 26, 2020	BUY	$42.19 - $69.61 $24,849 - $41,000	589 Added 9.23%	6,973 $469,000
Q1 2020 May 07, 2020	BUY	$23.16 - $47.8 $2,316 - $4,780	100 Added 1.59%	6,384 $201,000
Q4 2019 Feb 11, 2020	BUY	$27.97 - $40.38 $175,763 - $253,747	6,284 New	6,284 $254,000

3.38M

19.8K

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.03B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

Get notified when there are updates to the investment portfolio of Pro Vise Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Vise Management Group, LLC with notifications on news.